Author HORLICK, Robert A
CARACOTI, Andrei
YOWE, David L
BALANI, Suresh
CHE, Jennifer L
DRABIC, Stacey V
JOSEPH, Ingrid B. J. K
VOS, Tricia J
PATANE, Michael A
MAGUIRE, Martin P
CLAIBORNE, Christopher F
HANG ZENG
RODRIGUEZ, Luis E
FARRER, Cheryl A
DAI, Mingshi
PING LI
FORSYTH, Nancy E
LAMPPU, Diana
Author_xml – sequence: 1
  givenname: Tricia J
  surname: VOS
  fullname: VOS, Tricia J
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 2
  givenname: Andrei
  surname: CARACOTI
  fullname: CARACOTI, Andrei
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 3
  givenname: Suresh
  surname: BALANI
  fullname: BALANI, Suresh
  organization: Department of Drug Metabolism & Pharmacokinetics Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 4
  surname: PING LI
  fullname: PING LI
  organization: Department of Drug Metabolism & Pharmacokinetics Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 5
  surname: HANG ZENG
  fullname: HANG ZENG
  organization: Department of Drug Metabolism & Pharmacokinetics Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 6
  givenname: Ingrid B. J. K
  surname: JOSEPH
  fullname: JOSEPH, Ingrid B. J. K
  organization: Department of Cancer Chemotherapeutics, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, United States
– sequence: 7
  givenname: Luis E
  surname: RODRIGUEZ
  fullname: RODRIGUEZ, Luis E
  organization: Department of Cancer Chemotherapeutics, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, United States
– sequence: 8
  givenname: Martin P
  surname: MAGUIRE
  fullname: MAGUIRE, Martin P
  organization: Department of Cancer Chemotherapeutics, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, United States
– sequence: 9
  givenname: Michael A
  surname: PATANE
  fullname: PATANE, Michael A
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 10
  givenname: Christopher F
  surname: CLAIBORNE
  fullname: CLAIBORNE, Christopher F
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 11
  givenname: Jennifer L
  surname: CHE
  fullname: CHE, Jennifer L
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 12
  givenname: Mingshi
  surname: DAI
  fullname: DAI, Mingshi
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 13
  givenname: Cheryl A
  surname: FARRER
  fullname: FARRER, Cheryl A
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 14
  givenname: Nancy E
  surname: FORSYTH
  fullname: FORSYTH, Nancy E
  organization: Department of Medicinal Chemistry, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 15
  givenname: Stacey V
  surname: DRABIC
  fullname: DRABIC, Stacey V
  organization: Department of Molecular & Cellular Pharmacology, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 16
  givenname: Robert A
  surname: HORLICK
  fullname: HORLICK, Robert A
  organization: Department of Molecular & Cellular Pharmacology, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 17
  givenname: Diana
  surname: LAMPPU
  fullname: LAMPPU, Diana
  organization: Department of Molecular & Cellular Pharmacology, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
– sequence: 18
  givenname: David L
  surname: YOWE
  fullname: YOWE, David L
  organization: Department of Molecular & Cellular Pharmacology, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15599140$$DView record in Pascal Francis
BookMark eNqNjtFKxDAURIusYFf9h_si7MJeSNN2dZ9FWUHffBNZYnq7jSS5JUnVKv6wX2FFP8CnYYbDzMyzmWdPB1le1FJgdSGqWZYLISXKtSyPsnmMz0KIspBlnn3dNOSTaY1WybAHbkHih8QHiYsanwI7RomOUsdvY9-RH-0SJzfaRyyxtQMH_o0_sVrV2JhubAJjsUXjTKPe2QLB4u52OlCX5-tquQIF0SlrwbElPVgCR1Z51hyS8VBBIE194gDKJ7Vnb2KC1KkE1Lakk3khO05QM2iKkAbHAY3_cQ28ktl3CSzHCFOXmjaGOA1wQ_YkO2yVjXT6p8fZ2fXV_eUWexW1sm1QXpu464NxKoy7oq43m6IS5X-5bz3ceZw
CODEN JMCMAR
ContentType Journal Article
Copyright 2004 INIST-CNRS
Copyright_xml – notice: 2004 INIST-CNRS
DBID IQODW
DatabaseName Pascal-Francis
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-4804
EndPage 1604
ExternalDocumentID 15599140
GroupedDBID ---
-~X
.55
.GJ
.HR
.K2
08R
1KJ
1WB
3EH
3O-
4.4
53G
55A
5GY
5RE
5VS
6P2
6TJ
7~N
9M8
AABXI
AAUGY
AAYOK
ABFRP
ABHMW
ABMVS
ABOCM
ABPTK
ABQRX
ABTAH
ABUCX
ACGFO
ACGFS
ACJ
ACS
ADHLV
AEESW
AENEX
AFEFF
AFFNX
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
ANTXH
AQSVZ
BAANH
CS3
DU5
EBS
ED~
EJD
F5P
GGK
GNL
IH2
IH9
IHE
IQODW
JG~
L7B
LG6
MVM
NHB
OHT
P2P
RNS
ROL
TN5
UBC
UI2
VF5
VG9
W1F
WH7
X7M
XFK
XSW
YQT
YZZ
ZE2
ZGI
ZY4
ID FETCH-pascalfrancis_primary_155991403
ISSN 0022-2623
IngestDate Sun Oct 22 16:04:05 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Imidazole derivatives
Intravenous administration
Nitrogen heterocycle
Body weight
Central nervous system
Non peptide compound
Encephalon
Tissue
Subcutaneous administration
Antagonist
Chemical synthesis
Rodentia
Weight loss
Organic bromine compounds
Malignant tumor
Biological activity
Vertebrata
Amidine
Mammalia
MC4 melanocortin receptor
Mouse
Animal
Distribution
Organic fluorine compounds
Benzenic compound
Pharmacokinetics
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-pascalfrancis_primary_155991403
ParticipantIDs pascalfrancis_primary_15599140
PublicationCentury 2000
PublicationDate 2004
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
PublicationTitle Journal of medicinal chemistry
PublicationYear 2004
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
SSID ssj0003123
Score 3.5208008
SourceID pascalfrancis
SourceType Index Database
StartPage 1602
SubjectTerms Biological and medical sciences
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Title Identification of 2-{2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazol e (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGXuCFwQAxBtN5YNOm1FOu7foYOlCLuq2CgiYhNDmNIyKlyZSmggzxh_kVnBPn1mnj9mLFqWW1Pl99jj9_PmbspSWl5WGgz4Uh-hwnPJ8LaZs80J1ZYDleMCt4yJPT7vCD_fbcOV-7s9FSLS0z73B2deO5kv-xKr5Du9Ip2X-wbN0pvsBntC-WaGEs_8rG6pRtUNJuFPeZfLf3CguHCvPI4R7J7bjJi5uiv-Wk6MojXP5zrOODc8wtHkTLJE3Kj3rH3MZxd7gffsn9NOHGkIfz0BdXSaQVAenJmEIYnDKwXb9Qf2qLOe1wz9VVu1Kby0jECa5rszDWbA0nVXmZFWpN2gOjXL0Y74qsFJPgfBvl2MhfkjosW86TlIcx1Xzta8HcahG6cmJmhEZMhVT399wSV5dqAcp7Ul1mV6Hq45kSKqbE5TQbYgP3nTs4m45qgWdYkxTu2D0dKfVSKhc1dT4hjm88WqFMGrK03gWrszGU2ti2i8DVudlVh6APZekVcI1tH5UdlW5DJQot_x69lg8wurrZiiewajfOthIYXPPBtTKSdon7uOildAy6TRO3O3hfhxaWYVpV-nv6jqTkFQv8HYG6haUVGk0fsPvl2IOrAPqQrcl4k90dVKO_yfYmKkF63oFpc95v0YE9mDSp0_NH7OcqoiEJwOTfTf7J5Pu3YPlAIfnzNRz_4HbnRgyDhP0GwQcdEFCgFyr0Qhu9YEOFXmjQC4ReaKEXSvTCCnpBoRcIvYB9CSjQCwV6H7PdN6-ngyFfGdqLS5X95aKykPWErcdJLJ8ysASuUdF_-UbXs2e6LkyhO9LoSc9zZn5XbrGd3_f17E8Nttk9JRkj7u85W8_SpXyB0XDm7RQI-QWsrsPz
link.rule.ids 315,786,790,4043
linkProvider American Chemical Society
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+2-%7B2-%5B2-%285-bromo-2-methoxyphenyl%29-ethyl%5D-3-fluorophenyl%7D-4%2C5-dihydro-1H-imidazol+e+%28ML00253764%29%2C+a+small+molecule+melanocortin+4+receptor+antagonist+that+effectively+reduces+tumor-induced+weight+loss+in+a+mouse+model&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=VOS%2C+Tricia+J&rft.au=CARACOTI%2C+Andrei&rft.au=BALANI%2C+Suresh&rft.au=PING+LI&rft.date=2004&rft.pub=American+Chemical+Society&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=47&rft.issue=7&rft.spage=1602&rft.epage=1604&rft.externalDBID=n%2Fa&rft.externalDocID=15599140
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon